Multiple insulin degrading enzyme variants alter In Vitro reporter gene expression

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Belbin, Olivia ^a,b   Crump, Michael ^a   Bisceglio, Gina D ^a   Carrasquillo, Minerva M ^a   Morgan, Kevin ^b   Younkin, Steven G ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULINASE; LUCIFERASE;

ARTICLE; GENE EXPRESSION; GENE REPLICATION; GENE SEQUENCE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; IDE GENE; LIVER TUMOR; MOLECULAR CLONING; NEUROBLASTOMA CELL; PROMOTER REGION; REPORTER GENE; GENETICS; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; GENE EXPRESSION; GENES, REPORTER; HAPLOTYPES; HUMANS; INSULYSIN; LUCIFERASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79959413457     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021429     Document Type: Article

References (16)

1. Roher AE, Kasunic TC, Woods AS, Cotter RJ, Ball MJ, et al. (1994) Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A. Biochem Biophys Res Commun 205 (3): 1755-1761.
2. Backstrom JR, Lim GP, Cullen MJ, Tokes ZA, (1996) Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J Neurosci 16 (24): 7910-7919.
3. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, et al. (2000) Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6 (2): 143-150.
4. Hu J, Igarashi A, Kamata M, Nakagawa H, (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 276 (51): 47863-47868.
5. Kurochkin IV, Goto S, (1994) Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. 345 (1) FEBS Lett: 33-37.
6. McDermott JR, Gibson AM, (1997) Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. 22 (1) Neurochem Res: 49-56.
7. Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, et al. (1998) Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. 273 (49) J Biol Chem: 32730-32738.
8. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, et al. (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. 100 (7) U S A Proc Natl Acad Sci: 4162-4167.
9. Bernstein HG, Ansorge S, Riederer P, Reiser M, Frolich L, et al. (1999) Insulindegrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques. Neurosci Lett 263 (2-3): 161-164.
10. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, et al. (2003) Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12: 23-32.
11. Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, et al. (1999) A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 8: 237-245.
12. Bertram L, Blacker D, Mullin K, Keeney D, Jones J, et al. (2000) Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290: 2302-2303.
13. Prince JA, Feuk L, Gu HF, Johansson B, GatzM, et al. (2003) Genetic variation in a haplotype block spanning IDE influences Alzheimer disease. Hum Mutat 22: 363-371.
14. Ertekin-Taner N, Allen M, Fadale D, Scanlin L, Younkin L, et al. (2004) Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease. Hum Mutat 23: 334-342.
15. Carrasquillo MM, Belbin O, Zou F, Allen M, Ertekin-Taner N, et al. (2010) Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease. 5 (1) PLoS One e8764 in press.
16. Rockman MV, Wray GA, (2002) Abundant raw material for cis-regulatory evolution in humans. 19 (11) Mol Biol Evol: 1991-2004.